125 related articles for article (PubMed ID: 11567741)
1. Revised interpretation of the immunological results obtained with pneumococcal polysaccharide 17F derived synthetic di-, tri- and tetrasaccharide conjugates in mice and rabbits.
Jansen WT; Verheul AF; Veeneman GH; van Boom JH; Snippe H
Vaccine; 2001 Oct; 20(1-2):19-21. PubMed ID: 11567741
[TBL] [Abstract][Full Text] [Related]
2. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
Jansen WT; Hogenboom S; Thijssen MJ; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H; Verheul AF
Infect Immun; 2001 Feb; 69(2):787-93. PubMed ID: 11159969
[TBL] [Abstract][Full Text] [Related]
3. Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.
Alonso de Velasco E; Verheul AF; Veeneman GH; Gomes LJ; van Boom JH; Verhoef J; Snippe H
Vaccine; 1993 Nov; 11(14):1429-36. PubMed ID: 8310762
[TBL] [Abstract][Full Text] [Related]
4. Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice.
Benaissa-Trouw B; Lefeber DJ; Kamerling JP; Vliegenthart JF; Kraaijeveld K; Snippe H
Infect Immun; 2001 Jul; 69(7):4698-701. PubMed ID: 11402020
[TBL] [Abstract][Full Text] [Related]
5. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H
Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity and gene expression related to pneumococcal glycoconjugate.
Lee CJ; Li ZM
Adv Exp Med Biol; 2001; 491():505-14. PubMed ID: 14533818
[TBL] [Abstract][Full Text] [Related]
7. Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization.
Safari D; Dekker HA; de Jong B; Rijkers GT; Kamerling JP; Snippe H
Vaccine; 2011 Sep; 29(38):6498-504. PubMed ID: 21767596
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide--protein conjugate vaccine is decreased by admixture of high doses of free saccharide.
Peeters CC; Tenbergen-Meekes AM; Poolman JT; Zegers BJ; Rijkers GT
Vaccine; 1992; 10(12):833-40. PubMed ID: 1455909
[TBL] [Abstract][Full Text] [Related]
9. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).
Alexander J; del Guercio MF; Frame B; Maewal A; Sette A; Nahm MH; Newman MJ
Vaccine; 2004 Jun; 22(19):2362-7. PubMed ID: 15193395
[TBL] [Abstract][Full Text] [Related]
10. Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune response.
Perciani CT; Barazzone GC; Goulart C; Carvalho E; Cabrera-Crespo J; Gonçalves VM; Leite LC; Tanizaki MM
Clin Vaccine Immunol; 2013 Jun; 20(6):858-66. PubMed ID: 23554468
[TBL] [Abstract][Full Text] [Related]
11. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.
Rabquer B; Smithson SL; Shriner A; Julie Westerink MA
Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
[TBL] [Abstract][Full Text] [Related]
13. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
Anttila M; Eskola J; Ahman H; Käyhty H
J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
[TBL] [Abstract][Full Text] [Related]
14. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
[TBL] [Abstract][Full Text] [Related]
15. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.
Mawas F; Feavers IM; Corbel MJ
Vaccine; 2000 Dec; 19(9-10):1159-66. PubMed ID: 11137252
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.
de Velasco EA; Merkus D; Anderton S; Verheul AF; Lizzio EF; Van der Zee R; Van Eden W; Hoffman T; Verhoef J; Snippe H
Infect Immun; 1995 Mar; 63(3):961-8. PubMed ID: 7532630
[TBL] [Abstract][Full Text] [Related]
17. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
Caro-Aguilar I; Indrawati L; Kaufhold RM; Gaunt C; Zhang Y; Nawrocki DK; Giovarelli C; Winters MA; Smith WJ; Heinrichs J; Skinner JM
Vaccine; 2017 Feb; 35(6):865-872. PubMed ID: 28087148
[TBL] [Abstract][Full Text] [Related]
19. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide.
Paton JC; Lock RA; Lee CJ; Li JP; Berry AM; Mitchell TJ; Andrew PW; Hansman D; Boulnois GJ
Infect Immun; 1991 Jul; 59(7):2297-304. PubMed ID: 2050399
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
Väkeväinen M; Eklund C; Eskola J; Käyhty H
J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
